Camoutsis C, Catsoulacos D, Karayiann V, Papageorgiou A, Mourelatos D, Mioglou E, Kritsi Z, Nikolaropoulos S
Laboratory of Pharmaceutical Chemistry, Patras, Greece.
Cancer Detect Prev. 2001;25(6):558-64.
The present work was undertaken in order to test the hypothesis that the Sister Chromatid Exchange (SCE) assay in vitro can be used for the prediction of in vivo tumor response to newly synthesized potential chemotherapeutics. The effect of three homo-aza-steroidal esters containing the -CONH- in the steroidal nucleus, 1, 2, and 3 on SCE rates and on cell kinetics in cultured human lymphocytes was studied. The antitumor activity of these compounds was tested on leukemia P388- and leukemia L1210-bearing mice. The three substances induced statistically significant enhancement of SCEs and of cell division delays. Compounds 1 and 3 were identified, on a molar basis, as more effective inducers of SCEs and of cell division delays compared with compound 2. Compounds 1 and 3 had upon both experimental tumors better therapeutic effects compared with compound 2 at equitoxic doses. Therefore, the order of the antitumor effectiveness of the three compounds coincided with the order of the cytogenetic effects they induced.
体外姐妹染色单体交换(SCE)试验可用于预测体内肿瘤对新合成的潜在化疗药物的反应。研究了甾体核中含有-CONH-的三种同型氮杂甾体酯1、2和3对培养的人淋巴细胞中SCE率和细胞动力学的影响。在携带白血病P388和白血病L1210的小鼠身上测试了这些化合物的抗肿瘤活性。这三种物质均能使SCE和细胞分裂延迟在统计学上显著增加。以摩尔为基础,与化合物2相比,化合物1和3被确定为更有效的SCE和细胞分裂延迟诱导剂。在等毒性剂量下,化合物1和3对两种实验性肿瘤的治疗效果均优于化合物2。因此,这三种化合物的抗肿瘤有效性顺序与其诱导的细胞遗传学效应顺序一致。